Federico Monaco

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma

Luca Bertamini, Stefania Oliva, Delia Rota‐Scalabrini et al. · Journal of Clinical Oncology · 2022 · 88 citations · Full text

Medicine, Hematology, Oncology +17

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma

Alessandra Larocca, Francesca Bonello, Gianluca Gaïdano et al. · Blood · 2021 · 81 citations · Full text

Medicine, Geriatric Medicine, Oncology +12

Rituximab plus bendamustine as front-line treatment in frail elderly (&gt;70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>

Sergio Storti, Michele Spina, Emanuela Anna Pesce et al. · Haematologica · 2018 · 61 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

Cinzia Pellegrini, Anna Dodero, Annalisa Chiappella et al. · Journal of Hematology & Oncology · 2016 · 41 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas

Roberto Santi, Manuela Ceccarelli, Elisa Bernocco et al. · Thrombosis and Haemostasis · 2017 · 38 citations · Full text

Medicine, Hematology, Oncology +17